A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells

Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis

SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules

Protocol for production and purification of SARS-CoV-2 3CLpro

Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals

Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract

Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment

Identification of In Vitro Inhibitors of Monkeypox Replication

Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA

Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection

SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis Collection of Viral RNA-Binding Molecules